Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates

Go back to Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (ANEB) Reports In-Line Q4 EPS

September 29, 2025 4:07 PM EDT

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.

... More